Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution
ApprovedWithdrawn 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Peritoneal Dialysis
Conditions
Peritoneal Dialysis, Hypertriglyceridemia
Trial Timeline
Nov 1, 2006 โ Jun 1, 2007
NCT ID
NCT00397358About Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution
Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution is a approved stage product being developed by Baxter for Peritoneal Dialysis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00397358. Target conditions include Peritoneal Dialysis, Hypertriglyceridemia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00397358 | Approved | Withdrawn |
Competing Products
20 competing products in Peritoneal Dialysis